BROMPHENIRAMINE MALEATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Brompheniramine Maleate, and what generic alternatives are available?
Brompheniramine Maleate is a drug marketed by Alpharma Us Pharms, Kv Pharm, Pharm Assoc, Usl Pharma, Watson Labs, Barr, Ivax Sub Teva Pharms, Newtron Pharms, Nexgen Pharma Inc, Par Pharm, Pioneer Pharms, Upsher Smith Labs, Vitarine, Acella, Alkem Labs Ltd, Bionpharma, Chartwell Molecular, Dr Reddys Labs Sa, Padagis Us, Rhodes Pharms, Taro, and Wes Pharma Inc. and is included in twenty-six NDAs.
The generic ingredient in BROMPHENIRAMINE MALEATE is brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride. There are twenty-one drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BROMPHENIRAMINE MALEATE?
- What are the global sales for BROMPHENIRAMINE MALEATE?
- What is Average Wholesale Price for BROMPHENIRAMINE MALEATE?
Summary for BROMPHENIRAMINE MALEATE
| US Patents: | 0 |
| Applicants: | 22 |
| NDAs: | 26 |
| Raw Ingredient (Bulk) Api Vendors: | 72 |
| Clinical Trials: | 4 |
| Patent Applications: | 1,332 |
| DailyMed Link: | BROMPHENIRAMINE MALEATE at DailyMed |
Recent Clinical Trials for BROMPHENIRAMINE MALEATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Ache Laboratorios Farmaceuticos S.A. | Phase 3 |
| Wyeth is now a wholly owned subsidiary of Pfizer | Phase 1 |
Medical Subject Heading (MeSH) Categories for BROMPHENIRAMINE MALEATE
Anatomical Therapeutic Chemical (ATC) Classes for BROMPHENIRAMINE MALEATE
US Patents and Regulatory Information for BROMPHENIRAMINE MALEATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alpharma Us Pharms | BROMPHENIRAMINE MALEATE | brompheniramine maleate | ELIXIR;ORAL | 086936-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Alkem Labs Ltd | BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE | brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride | SYRUP;ORAL | 210647-001 | Jul 14, 2020 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Rhodes Pharms | BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE | brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride | SYRUP;ORAL | 202955-001 | Nov 5, 2020 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Barr | BROMPHENIRAMINE MALEATE | brompheniramine maleate | TABLET;ORAL | 084468-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Usl Pharma | BROMPHENIRAMINE MALEATE | brompheniramine maleate | ELIXIR;ORAL | 087964-001 | Jan 25, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pioneer Pharms | BROMPHENIRAMINE MALEATE | brompheniramine maleate | TABLET;ORAL | 088604-001 | Jul 13, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
